# BORTEZOMIB
> **NDA209191** · New Drug Application · Sponsor: HOSPIRA · Approved 2022-05-02
## Drug
- **FDA Application Number:** NDA209191
- **Application type:** New Drug Application
- **Brand name:** BORTEZOMIB
- **Generic name:** BORTEZOMIB
- **Active ingredients:** BORTEZOMIB
- **Dosage form:** POWDER
- **Route:** INTRAVENOUS, SUBCUTANEOUS
- **Marketing status:** Prescription
- **Sponsor:** HOSPIRA
- **Manufacturer:** Hospira, Inc.
- **First approval:** 2022-05-02
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209191)
---
*AI Analytics · CC0 1.0*